PNC Financial Services Group’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,325
Closed -$7.2K 5233
2025
Q2
$7.2K Buy
1,325
+702
+113% +$3.5K ﹤0.01% 3999
2025
Q1
$2.16K Buy
623
+43
+7% +$208 ﹤0.01% 4317
2024
Q4
$5.97K Hold
580
﹤0.01% 3980
2024
Q3
$7.86K Hold
580
﹤0.01% 3879
2024
Q2
$7.54K Buy
580
+22
+4% +$272 ﹤0.01% 3871
2024
Q1
$5.27K Buy
558
+10
+2% +$97 ﹤0.01% 3943
2023
Q4
$6.01K Sell
548
-2,433
-82% -$19.3K ﹤0.01% 3892
2023
Q3
$19K Buy
2,981
+2,441
+452% +$14.9K ﹤0.01% 3449
2023
Q2
$2.6K Hold
540
﹤0.01% 4303
2023
Q1
$2.23K Buy
+540
New +$2.29K ﹤0.01% 4282

Other funds holding THRD

PNC Financial Services Group's THRD Position: Q3 2025 in Review

PNC Financial Services Group sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 1,325 shares — an estimated $7.2K sold.

PNC Financial Services Group first reported a position in THRD in Q1 2023 and held it in 10 quarters. The position peaked at $19K in Q3 2023. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • PNC Financial Services Group reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 1,325 Third Harmonic Bio shares in Q3 2025, an estimated $7.2K.
  • PNC Financial Services Group first reported a position in Third Harmonic Bio in Q1 2023 and held it in 10 quarters.
  • PNC Financial Services Group's Third Harmonic Bio position peaked at $19K in Q3 2023.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on PNC Financial Services Group's 13F filing for Q3 2025, filed 7 Nov 2025.